News and Trends 30 Jun 2022
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
…($1.2 million) in the project anticipated to take place over a one-year period. Parkinson’s Disease Domainex will be focused on medicines for the treatment of Parkinson’s Disease, motor neuron disease…